Rockwell medical expands partnership with davita

$7.5m initial equity investment in rockwell amended and expanded supply agreement strengthens rockwell's financial position, laying groundwork for improved concentrate business wixom, mich., april 11, 2022 /prnewswire/ -- rockwell medical, inc. (nasdaq: rmti), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today announced an expanded partnership with davita inc. (nyse: dva), a leading kidney care provider.
DVA Ratings Summary
DVA Quant Ranking